banner

Latest News

Wild Earth Introduces Cultured Clean Protein for $30B Pet Food Market

From PR Newswire: Wild Earth Introduces Cultured Clean Protein for $30B Pet Food Market BERKELEY, Calif., March 15, 2018 /PRNewswire/ -- Wild Earth, Inc., a biotech startup, announced today it is using cultured proteins to develop clean, high-quality pet foods for the $30 billion pet food market. Much like biotech companies creating cultured meats for human consumpt...

Read More

Synthetic Biology Firm Evonetix Raises $12.3M

A recent article on Evonetix: Synthetic biology firm Evonetix announced today that it has closed a $12.3 million financing round. The financing was co-led by Data Collective and Draper Esprit, and included Morningside Group along with existing investors Providence Investment Company, Cambridge Consultants, Rising Tide Fund, and Civilization Ventures. Evonetix was spun out of Ca...

Read More

Manus Bio Awarded Funding to Develop Novel Production Method for Artemisinin

A recent article about Manus BIo: Manus Bio Inc. (Manus Bio), a company which produces complex natural products through advanced fermentation, announced today that it has received funding from the Bill & Melinda Gates Foundation for the development of a scalable and cost-effective production method for artemisinin, a key therapeutic for treating malaria. Manus Bio will use its ...

Read More

Johnson & Johnson Partner with Aspect Biosystems to Create 3D Printed Knee

From 3D Printing Industry: Johnson & Johnson Partner with Aspect Biosystems to Create 3D Printed Knee Having announced partnerships with Carbon and HP last year, pharmaceutical company Johnson & Johnson (J&J) have now outlined plans to integrate 3D printing into the development of medical devices. Johnson & Johnson have just revealed a new partnership with Aspect Biosystems and their ...

Read More

Alveo Closes $38 Million in Series A Financing to Create Accessible Diagnostics Devices

A recent article on Alveo Technologies $38M Series A: Alveo Technologies, Inc., ("Alveo" or "the Company") whose mission it is to create affordable and accessible infectious disease diagnostic devices, announced the closing of a $38 million Series A financing raised by Maxim Merchant Capital, a division of Maxim Group LLC. The round was oversubscribed and included existing and ...

Read More

Rocket Pharmaceuticals and Inotek Pharmaceuticals Complete Merger Transaction

A recent article on Rocket Pharma merger and NASDAQ Listing: Rocket Pharmaceuticals, Ltd., a leading U.S.-based multi-platform gene therapy company addressing challenging rare diseases, today announced the completion of its merger with Inotek Pharmaceuticals Corporation Rocket utilizes a multi-platform development approach that leverages the well-established lentiviralvector (LVV)...

Read More


Evonetix can be as big as Solexa, says Hauser

A recent article in Business Weekly on Evonetix: Dr Hauser, who has supported the company from birth, says: “Evonetix will do to gene-synthesis what Solexa did to gene-sequencing – revolutionise it. “There has been an architectural breakthrough which allows Evonetix to produce base-accurate genes of any length at a cost and speed that is orders of magnitude cheaper and faster than ...

Read More

Aspect Biosystems CEO Tamer Mohamed Named to Top 40 Under 40

A recent article on Aspect Biosystems CEO: We are proud to announce that our CEO Tamer Mohamed has been selected by Business in Vancouver for their annual Forty Under 40 Awards. These awards highlight the achievements of 40 of British Columbia's outstanding young entrepreneurs, executives, and professionals. All winners are under 40 years old and have demonstrated excellence in...

Read More

Start-up working on breakthrough in 3-D printing of human organs

A recent article on Prellis Biologics raising $1.8 million in new seed funding: Prellis Biologics, a human tissue engineering company, has invented a new way to create what it says are viable human organs using near instantaneous 3-D printing. This type of development, if proven out, could be a boon for hospitals and health systems with long lists of patients waiting for donor ...

Read More